Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Identification of Novel Aurora Kinase A (AURKA) Inhibitors via Hierarchical Ligand-Based Virtual Screening
Yue Kong, Andreas Bender, Aixia Yan
Journal of Chemical Information and Modeling (2017) Vol. 58, Iss. 1, pp. 36-47
Closed Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Artificial intelligence to deep learning: machine intelligence approach for drug discovery
Rohan Gupta, Devesh Srivastava, Mehar Sahu, et al.
Molecular Diversity (2021) Vol. 25, Iss. 3, pp. 1315-1360
Open Access | Times Cited: 889
Advances in the Development of Shape Similarity Methods and Their Application in Drug Discovery
Ashutosh Kumar, Kam Y. J. Zhang
Frontiers in Chemistry (2018) Vol. 6
Open Access | Times Cited: 169
Insights into the non-mitotic functions of Aurora kinase A: more than just cell division
Giulia Bertolin, Marc Tramier
Cellular and Molecular Life Sciences (2019) Vol. 77, Iss. 6, pp. 1031-1047
Open Access | Times Cited: 73
Applications of Quantitative Structure-Activity Relationships (QSAR) based Virtual Screening in Drug Design: A Review
P. Ganga Raju Achary
Mini-Reviews in Medicinal Chemistry (2020) Vol. 20, Iss. 14, pp. 1375-1388
Closed Access | Times Cited: 54
Recent advances in drug repurposing using machine learning
Fabio Urbina, Ana C. Puhl, Sean Ekins
Current Opinion in Chemical Biology (2021) Vol. 65, pp. 74-84
Open Access | Times Cited: 46
Predictions of genotoxic potential, mode of action, molecular targets, and potency via a tiered multiflow® assay data analysis strategy
Stephen D. Dertinger, Andrew R. Kraynak, Ryan P. Wheeldon, et al.
Environmental and Molecular Mutagenesis (2019) Vol. 60, Iss. 6, pp. 513-533
Open Access | Times Cited: 35
Mitochondrial Aurora kinase A induces mitophagy by interacting with MAP1LC3 and Prohibitin 2
Giulia Bertolin, Marie‐Clotilde Alves‐Guerra, Angélique Cheron, et al.
Life Science Alliance (2021) Vol. 4, Iss. 6, pp. e202000806-e202000806
Open Access | Times Cited: 27
Visualization strategies to aid interpretation of high‐dimensional genotoxicity data
Stephen D. Dertinger, Erica M. Briggs, Yusuf Hussien, et al.
Environmental and Molecular Mutagenesis (2024) Vol. 65, Iss. 5, pp. 156-178
Open Access | Times Cited: 3
Design and Evaluation of Potent EGFR Inhibitors through the Incorporation of Macrocyclic Polyamine Moieties into the 4-Anilinoquinazoline Scaffold
Yilan Ju, Jintao Wu, Xi Yuan, et al.
Journal of Medicinal Chemistry (2018) Vol. 61, Iss. 24, pp. 11372-11383
Closed Access | Times Cited: 30
A comprehensive comparison of molecular feature representations for use in predictive modeling
Tomaž Stepišnik, Blaž Škrlj, Jörg Wicker, et al.
Computers in Biology and Medicine (2021) Vol. 130, pp. 104197-104197
Closed Access | Times Cited: 22
The role of artificial intelligence in the development of anticancer therapeutics from natural polyphenols: Current advances and future prospects
Ying Zheng, Yifei Ma, Qunli Xiong, et al.
Pharmacological Research (2024) Vol. 208, pp. 107381-107381
Open Access | Times Cited: 2
Virtual Screening Approach for the Identification of Hydroxamic Acids as Novel Human Ecto-5′-Nucleotidase Inhibitors
Lucas G. Viviani, Erika Piccirillo, Henning Ulrich, et al.
Journal of Chemical Information and Modeling (2019) Vol. 60, Iss. 2, pp. 621-630
Closed Access | Times Cited: 20
Virtual Screening in the Cloud Identifies Potent and Selective ROS1 Kinase Inhibitors
Dušan Petrović, James S. Scott, Michael S. Bodnarchuk, et al.
Journal of Chemical Information and Modeling (2022) Vol. 62, Iss. 16, pp. 3832-3843
Closed Access | Times Cited: 12
Aneugen Molecular Mechanism Assay: Proof-of-Concept With 27 Reference Chemicals
Derek T. Bernacki, Steven M. Bryce, Jeffrey C. Bemis, et al.
Toxicological Sciences (2019) Vol. 170, Iss. 2, pp. 382-393
Open Access | Times Cited: 16
Shape similarity guided pose prediction: lessons from D3R Grand Challenge 3
Ashutosh Kumar, Kam Y. J. Zhang
Journal of Computer-Aided Molecular Design (2018) Vol. 33, Iss. 1, pp. 47-59
Closed Access | Times Cited: 12
MUBD‐DecoyMaker 2.0: A Python GUI Application to Generate Maximal Unbiased Benchmarking Data Sets for Virtual Drug Screening
Jie Xia, Shan Li, Yu Ding, et al.
Molecular Informatics (2019) Vol. 39, Iss. 4
Closed Access | Times Cited: 11
Discovery of Novel Epidermal Growth Factor Receptor (EGFR) Inhibitors Using Computational Approaches
Donghui Huo, Shiyu Wang, Yue Kong, et al.
Journal of Chemical Information and Modeling (2021) Vol. 62, Iss. 21, pp. 5149-5164
Closed Access | Times Cited: 9
Classification models and SAR analysis on HDAC1 inhibitors using machine learning methods
Rourou Li, Yujia Tian, Zhenwu Yang, et al.
Molecular Diversity (2022) Vol. 27, Iss. 3, pp. 1037-1051
Closed Access | Times Cited: 6
Identification of an AXL kinase inhibitor in triple‐negative breast cancer by structure‐based virtual screening and bioactivity test
Pei Li, Yuzhen Niu, Shuyan Li, et al.
Chemical Biology & Drug Design (2021) Vol. 99, Iss. 2, pp. 222-232
Closed Access | Times Cited: 8
Building 2D classification models and 3D CoMSIA models on small-molecule inhibitors of both wild-type and T790M/L858R double-mutant EGFR
Donghui Huo, Hongzhao Wang, Zijian Qin, et al.
Molecular Diversity (2021) Vol. 26, Iss. 3, pp. 1715-1730
Closed Access | Times Cited: 7
Fingerprint‐based computational models of 5‐lipo‐oxygenase activating protein inhibitors: Activity prediction and structure clustering
Guiping Tu, Zijian Qin, Donghui Huo, et al.
Chemical Biology & Drug Design (2020) Vol. 96, Iss. 3, pp. 931-947
Closed Access | Times Cited: 7
Mitochondrial Aurora kinase A induces mitophagy by interacting with MAP1LC3 and Prohibitin 2
Giulia Bertolin, Marie‐Clotilde Alves‐Guerra, Angélique Cheron, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 6
Ligand and structure based hierarchical virtual screening cascade for finding novel epidermal growth factor receptor inhibitors
Donghui Huo, Zhiqi Sun, Maolin Wang, et al.
Chemical Biology & Drug Design (2023) Vol. 103, Iss. 1
Closed Access | Times Cited: 2
Pharmacophore Synergism in Diverse Scaffold Clinches in Aurora Kinase B
Vijay H. Masand, Sami A. Al‐Hussain, Mithilesh M. Rathore, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14527-14527
Open Access | Times Cited: 4
Scaffold hopping approaches for dual-target antitumor drug discovery: opportunities and challenges
Anshul Mishra, Amandeep Thakur, Ram Lal Sharma, et al.
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 11, pp. 1355-1381
Closed Access
Page 1 - Next Page

Scroll to top